Intec Pharma Ltd
WHO'M
ai
Digital Profiler. Simply click the AI button
FIGI: -
NTEC
Intec Pharma Ltd
GICS: -
·
Sector: Healthcare
·
Sub-Sector: Biotechnology
NAME
Intec Pharma Ltd
ISIN
IL0011177958
TICKER
NTEC
MIC
XNAS
REUTERS
NTEC.OQ
BLOOMBERG
NTEC US
F&G:
35
Financial Intelligence
FOR INVESTORS
FOR TRADERS
Securities Trading
Warrants
GlobeNewswire is an important news source that provides investors with company-related information. In particular, it deals with events that may be relevant to the listing of companies or tradable financial instruments. You can access the complete overview of all reports via this link.
Mon, 12.08.2024
NEW YORK, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announced financial results for the second quarter ended June 30, 2024, and provided a corporate update.
Wed, 08.05.2024
Company to present poster at American Society of Clinical Oncology (ASCO) Annual Meeting on June 1, 2024 highlighting initial results from its Phase 1 clinical trial of Decoy20
Company to present poster at American Society of Clinical Oncology (ASCO) Annual Meeting on June 1, 2024 highlighting initial results from its Phase 1 clinical trial of Decoy20
Information on product placements
SMART * AD
P R O D U C T S U G G E S T I O N S
